Kite Pharma, Inc. Form SC14D9C: Written communication by the subject company on a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-09-01: Form SC14D9C; Description SC14D9C; Document d448326dsc14d9c.htm.
- 2017-08-28: Form SC14D9C; Description SC14D9C; Document d448326dsc14d9c.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2017-09-01 | SC14D9C | SC14D9C | d448326dsc14d9c.htm | |
| 2017-08-28 | SC14D9C | SC14D9C | d448326dsc14d9c.htm |